Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.10 (
IKK
)
4,900
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Signaling via the inducible costimulator
ICOS
fuels the stepwise development of follicular helper T cells (TFH cells). However, a signaling pathway unique to
ICOS
has not been identified. We found here that the kinase
TBK1
associated with
ICOS
via a conserved motif, IProx, that shares homology with the tumor-necrosis-factor receptor (TNFR)-associated factors TRAF2 and TRAF3. Disruption of this motif abolished the association of
TBK1
with
ICOS
, TRAF2 and TRAF3, which identified a
TBK1
-binding consensus. Alteration of this motif in
ICOS
or depletion of
TBK1
in T cells severely impaired the differentiation of germinal center (GC) TFH cells and the development of GCs, interfered with B cell differentiation and disrupted the development of antibody responses, but the IProx motif and
TBK1
were dispensable for the early differentiation of TFH cells. These results reveal a previously unknown
ICOS
-
TBK1
signaling pathway that specifies the commitment of GC TFH cells.
...
PMID:A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1. 2743 13
Follicular helper T (T
FH
) cells represent a highly specialized CD4
+
T cell subpopulation that supports the generation of germinal centers (GC) and provides B cells with critical signals promoting antibody class switching, generation of high affinity antibodies, and memory formation. T
FH
cells are characterized by the expression of the chemokine receptor CXCR5, the transcription factor Bcl-6, costimulatory molecules
ICOS
, and PD-1, and the production of cytokine IL-21. The acquisition of a T
FH
phenotype is a complex and multistep process that involves signals received through engagement of the TCR along with a multitude of costimulatory molecules and cytokines receptors. Members of the Tumor necrosis factor Receptor Associated Factors (TRAF) represent one of the major classes of signaling mediators involved in the differentiation and functions of T
FH
cells. TRAF molecules are the canonical adaptor molecules that physically interact with members of the Tumor Necrosis Factor Receptor Superfamily (TNFRSF) and actively modulate their downstream signaling cascades through their adaptor function and/or E3 ubiquitin ligase activity. OX-40, GITR, and 4-1BB are the TRAF-dependent TNFRSF members that have been implicated in the differentiation and functions of T
FH
cells. On the other hand, emerging data demonstrate that TRAF proteins also participate in signaling from the TCR and CD28, which deliver critical signals leading to the differentiation of T
FH
cells. More intriguingly, we recently showed that the cytoplasmic tail of
ICOS
contains a conserved
TANK-binding kinase 1
(
TBK1
)-binding motif that is shared with
TBK1
-binding TRAF proteins. The presence of this TRAF-mimicking signaling module downstream of
ICOS
is required to mediate the maturation step during T
FH
differentiation. In addition, JAK-STAT pathways emanating from IL-2, IL-6, IL-21, and IL-27 cytokine receptors affect T
FH
development, and crosstalk between TRAF-mediated pathways and the JAK-STAT pathways can contribute to generate integrated signals required to drive and sustain T
FH
differentiation. In this review, we will introduce the molecular interactions and the major signaling pathways controlling the differentiation of T
FH
cells. In each case, we will highlight the contributions of TRAF proteins to these signaling pathways. Finally, we will discuss the role of individual TRAF proteins in the regulation of T cell-dependent humoral responses.
...
PMID:Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses. 3040 12
Human patients with homozygous null mutations in the
ICOS
gene suffer from recurrent infections due to humoral immune defects. Studies on human patients and mouse models have shown that
inducible T-cell co-stimulator
(
ICOS
)-deficient individuals cannot form T follicular helper (Tfh) cells, a group of CD4 T cells that migrate into B cell follicles and facilitate germinal center (GC) reactions.
ICOS
-induced phosphoinositide 3-kinase signaling pathways have been shown to play critical roles in Tfh programming, migration of Tfh cells into the GC, and delivery of T cell help during Tfh-GC B cell conjugation. These processes are also assisted by
ICOS
-mediated intracellular calcium mobilization and
TANK-binding kinase 1
signaling. However,
ICOS
signaling also has stimulatory roles in T regulatory cells and innate lymphoid cells (ILCs), providing another layer of complexity. In this review, we discuss cell-type-specific signaling mechanisms utilized by
ICOS
in Tfh cells, T regulatory cells, and ILCs. Whenever relevant, we compare the roles and signaling pathways of
ICOS
and CD28. Understanding
ICOS
signal transduction mechanisms used by distinct immune subsets at different stages of immune responses or disease progression may help improve vaccination protocols, treat autoimmune diseases, and enhance cancer immunotherapy.
...
PMID:Inducible T-cell co-stimulator: Signaling mechanisms in T follicular helper cells and beyond. 3140 4